Incidence of malignancies in patients with IgG4-related disease

Internal Medicine

Volumn 53, Issue 3, 2014, Pages 171-176

  Hirano, Kenji ^a   Tada, Minoru ^a   Sasahira, Naoki ^a   Isayama, Hiroyuki ^a   Mizuno, Suguru ^a   Takagi, Kaoru ^a   Watanabe, Takeo ^a   Saito, Tomotaka ^a   Kawahata, Shuhei ^a   Uchino, Rie ^a   Hamada, Tsuyoshi ^a   Miyabayashi, Koji ^a   Mohri, Dai ^a   Sasaki, Takashi ^a   Kogure, Hirofumi ^a   Yamamoto, Natsuyo ^a   Nakai, Yousuke ^a   Yoshida, Haruhiko ^a   Ito, Yukiko ^b   Akiyama, Dai ^b   Toda, Nobuo ^c   Arizumi, Toshihiko ^c   Yagioka, Hiroshi ^d   Takahara, Naminatsu ^e   Matsubara, Saburo ^f   Yashima, Yoko ^g   Koike, Kazuhiko ^a   more..

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^c MITSUI MEMORIAL HOSPITAL   (Japan)

^d JR Tokyo General Hospital   (Japan)

^e Mutual Aid Association of Public School Teachers   (Japan)

^f TOKYO METROPOLITAN POLICE HOSPITAL   (Japan)

^g Kyoundo Hospital   (Japan)

Author keywords

Autoimmune pancreatitis; Diabetes mellitus; IgG4 related disease; Malignancy

Indexed keywords

PREDNISOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; AUTOIMMUNE PANCREATITIS; BILE DUCT CANCER; BREAST CANCER; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN G4 RELATED DISEASE; INCIDENCE; KIDNEY CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MIDDLE AGED; NEOPLASM; PANCREAS CANCER; RISK FACTOR; STOMACH CANCER; TONGUE CANCER;

AGED; AUTOIMMUNE DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES;

EID: 84893500206     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.1342     Document Type: Article

References (22)

1. Sah RP, Chari ST. Long term prognosis in IgG4-related systemic disease. Curr Immunol Rev 7: 239-245, 2011.
2. Hirano K, Tada M, Isayama H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 56: 1719-1724, 2007.
3. Kubota K, Iida H, Fujisawa T, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc 66: 1142-1151, 2007.
4. Takuma K, Kamisawa T, Tabata T, Inaba Y, Egawa N, Igarashi Y. Short-term and long-term outcomes of autoimmune pancreatitis. Eur J Gastroenterol Hepatol 23: 146-152, 2011.
5. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40: 1561-1568, 1995.
6. Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society. Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society. Suizo (J Jpn Panc Soc) 17: 585-587, 2002 (in Japanese).
7. Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 41: 626-631, 2006.
8. Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 43: 403-408, 2008.
9. Chari ST, Takahashi N, Levy MJ, et al. Diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 7: 1097-1103, 2009.
10. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 40: 352-358, 2011.
11. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheu-matol 22: 21-30, 2012.
12. Matsuda T, Marugame T, Kamo K, et al. Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol 42: 139-147, 2012.
13. Ury HK, Wiggins AD. Another shortcut method for calculating the confidence interval of a Poisson variable (or of a standardized mortality ratio). Am J Epidemiol 122: 197-198, 1985.
14. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc 53: 450-467, 2010 (in Japanese).
15. Kawakubo K, Tada M, Isayama H, et al. Incidence of extrapancre-atic malignancies in patients with intraductal papillary mucinous neoplasms of the pancreas. Gut 60: 1249-1253, 2011.
16. Yamamoto M, Takahashi H, Tabeya T, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol 22: 414-418, 2012.
17. Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol 108: 610-617, 2013.
18. Hirakawa Y, Ninomiya T, Mukai N, et al. Association between glucose tolerance level and cancer death in a general Japanese population: the Hisayama Study. Am J Epidemiol 176: 856-864, 2012.
19. Hirano K, Tada M, Isayama H, Sasahira N, Koike K. Significance of measuring IgG and IgG4 during follow-up of autoimmune pancreatitis. Pancreas 40: 788-791, 2011.
20. Schwartzbaum J, Ding B, Johannesen TB, et al. Association between prediagnostic IgE levels and risk of glioma. J Natl Cancer Inst 104: 1251-1259, 2012.
21. Hirano K, Tada M, Mizuno S, et al. Lower incidence of biliary carcinoma in patients with primary sclerosing cholangitis and high serum levels of Immunoglobulin E. Clin Gastroenterol Hepatol 10: 79-83, 2012.
22. Van Hemelrijck M, Garmo H, Binda E, et al. Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study. Cancer Causes Control 21: 1657-1667, 2010.